奥精医疗1月29日获融资买入1307.94万元，融资余额2.25亿元

Group 1 - On January 29, Aojing Medical experienced a decline of 3.34% with a transaction volume of 86.96 million yuan, and the net financing buy was -45,500 yuan [1] - As of January 29, the total margin balance for Aojing Medical was 225 million yuan, accounting for 7.09% of its circulating market value, indicating a high level compared to the past year [1] - The company specializes in high-end biomedical materials and related medical device products, with its main revenue sources being 骼金 (74.91%), 颅瑞 (16.35%), and others [1] Group 2 - As of September 30, Aojing Medical had 9,862 shareholders, an increase of 15.44%, while the average circulating shares per person decreased by 13.37% [2] - For the period from January to September 2025, Aojing Medical reported a revenue of 156 million yuan, a year-on-year increase of 5.22%, and a net profit attributable to shareholders of 13.94 million yuan, up 185.19% year-on-year [2] - The company has distributed a total of 58.67 million yuan in dividends since its A-share listing, with 22.40 million yuan distributed in the last three years [3]